These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 16287454)

  • 1. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy.
    Eardley I; Mirone V; Montorsi F; Ralph D; Kell P; Warner MR; Zhao Y; Beardsworth A
    BJU Int; 2005 Dec; 96(9):1323-32. PubMed ID: 16287454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.
    Dean J; Hackett GI; Gentile V; Pirozzi-Farina F; Rosen RC; Zhao Y; Warner MR; Beardsworth A
    J Sex Med; 2006 Jul; 3(4):650-661. PubMed ID: 16839321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference.
    Ströberg P; Murphy A; Costigan T
    Clin Ther; 2003 Nov; 25(11):2724-37. PubMed ID: 14693300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy.
    Bai WJ; Li HJ; Dai YT; He XY; Huang YR; Liu JH; Sorsaburu S; Ji C; Jin JJ; Wang XF
    Asian J Androl; 2015; 17(1):61-7. PubMed ID: 25370206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.
    Govier F; Potempa AJ; Kaufman J; Denne J; Kovalenko P; Ahuja S
    Clin Ther; 2003 Nov; 25(11):2709-23. PubMed ID: 14693299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY; Lee SW; Kim SW; Yang DY; Park NC; Min KS; Park K; Paick JS; Dyachkova Y; Dwight T; Lee MS
    Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction.
    Rosen R; Broderick G; Shabsigh R; Swindle R; Lockhart D; Cameron A
    J Sex Med; 2005 Jul; 2(4):461-8. PubMed ID: 16422840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study.
    Conaglen HM; Conaglen JV
    J Sex Med; 2008 May; 5(5):1198-1207. PubMed ID: 18312284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners.
    Brock G; Chan J; Carrier S; Chan M; Salgado L; Klein AH; Lang C; Horner R; Gutkin S; Dickson R
    BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E; Porst H; Eardley I; Goldstein I
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study.
    Hatzimouratidis K; Buvat J; Büttner H; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    Int J Impot Res; 2014; 26(6):223-9. PubMed ID: 24784894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil or vardenafil nonresponders' erectile response to tadalafil.
    Ozgur BC; Gonenc F; Yazicioglu AH
    Urol J; 2009; 6(4):267-71. PubMed ID: 20027555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR; Campaña JMC; Ciutat LF; Miranda EF
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Eardley I; Wright P; MacDonagh R; Hole J; Edwards A
    BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.